Novel Chlamydia Vaccine Shows Promise in Early Trial

(MedPage Today) -- An investigational vaccine against chlamydia (CTH522) induced neutralizing antibodies in all participants who received it, and with no major safety concerns, results of a phase I trial showed. A 100% fourfold seroconversion...
Source: MedPage Today Public Health - Category: American Health Source Type: news